Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Verastem (VSTM) over the last 3 years, with Sep 2025 value amounting to $48.3 million.

  • Verastem's Other Non-Current Liabilities rose 84.76% to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.3 million, marking a year-over-year increase of 84.76%. This contributed to the annual value of $58.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Verastem reported Other Non-Current Liabilities of $48.3 million as of Q3 2025, which was up 121.96% from $21.8 million recorded in Q2 2025.
  • Verastem's Other Non-Current Liabilities' 5-year high stood at $58.2 million during Q4 2024, with a 5-year trough of $51,000 in Q3 2023.
  • For the 3-year period, Verastem's Other Non-Current Liabilities averaged around $34.9 million, with its median value being $37.2 million (2024).
  • Data for Verastem's Other Non-Current Liabilities shows a peak YoY soared of 51,150.98% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Verastem's Other Non-Current Liabilities stood at $51,000 in 2023, then spiked by 51,150.98% to $58.2 million in 2024, then skyrocketed by 84.76% to $48.3 million in 2025.
  • Its Other Non-Current Liabilities stands at $48.3 million for Q3 2025, versus $21.8 million for Q2 2025 and $54.7 million for Q1 2025.